Target intelligence / Profile preview

26S proteasome non-ATPase regulatory subunit 1 (Rpn2)

Target
Rpn2
Molecular classification
Enzyme subunit (non-catalytic), Ubiquitin-proteasome system component, Proteasome regulatory subunit, Other: Protein complex component
01

Overview

The 26S proteasome non-ATPase regulatory subunit 1 (Rpn2/PSMD1) is the largest non-ATPase subunit of the 19S regulator "base" of the 26S proteasome. It is essential for proteasome assembly and stability, situated at the central base of the 19S regulatory particle (RP). Rpn2 is involved in substrate recognition, assembly of the RP, and structural support for protein degradation machinery. The 19S RP together with the 20S core forms the complete 26S proteasome, critical for regulated proteolysis of polyubiquitinated proteins, affecting processes such as cell cycle, apoptosis, and antigen presentation. Note: "Proteasome 26S subunit, non-ATPase 1" most commonly maps to PSMD1/Rpn2 in human nomenclature. If referring generically to any non-ATPase 26S subunit, specify the gene or UniProt entry for precise mapping.

Other names
PSMD1Rpn226S proteasome regulatory subunit Rpn2
02

Mechanism of action

Inhibition of proteasome-mediated protein degradation; Induction of apoptosis via accumulation of misfolded proteins; Interruption of cell cycle progression. (General for proteasome inhibitors; direct targeting of Rpn2 with drugs is rare, but affecting the 19S subunit function is under investigation)

03

Biological functions

Protein degradationCell cycle regulationApoptosisAntigen processing (for MHC class I presentation)Cellular homeostasis
04

Disease associations

CancerNeurodegenerative diseaseInflammationInfection
05

Safety considerations

Off-target protein degradation issuesImmunosuppressionNeurotoxicityResistance development in cancer
06

Interacting drugs

Bortezomib

3 more in the full profile.

07

Biomarkers

Proteasome subunit expression (including PSMD1/Rpn2) is sometimes measured for disease state, especially in cancer and neurodegeneration

Beyond the preview

Go deeper on 26S proteasome non-ATPase regulatory subunit 1 (Rpn2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 26S proteasome non-ATPase regulatory subunit 1 (Rpn2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call